Polycystin-1 Surface Localization Is Stimulated by Polycystin-2 and Cleavage at the G Protein-coupled Receptor Proteolytic Site by Chapin, Hannah C. et al.
Molecular Biology of the Cell
Vol. 21, 4338–4348, December 15, 2010
Polycystin-1 Surface Localization Is Stimulated by
Polycystin-2 and Cleavage at the G Protein-coupled
Receptor Proteolytic Site
Hannah C. Chapin,* Vanathy Rajendran,† and Michael J. Caplan*†
Departments of *Cell Biology and †Cellular and Molecular Physiology, Yale University School of Medicine,
New Haven, CT 06520
Submitted May 7, 2010; Revised October 18, 2010; Accepted October 19, 2010
Monitoring Editor: Keith E. Mostov
Polycystin (PC)1 and PC2 are membrane proteins implicated in autosomal dominant polycystic kidney disease. A physio-
logically relevant cleavage at PC1’s G protein-coupled receptor proteolytic site (GPS) occurs early in the secretory pathway.
Our results suggest that PC2 increases both PC1 GPS cleavage and PC1’s appearance at the plasma membrane. Mutations that
prevent PC1’s GPS cleavage prevent its plasma membrane localization. PC2 is a member of the trp family of cation channels
and is an important PC1 binding partner. The effect of PC2 on PC1 localization is independent of PC2 channel activity, as
tested using channel-inhibiting PC2 mutations. PC1 and PC2 can interact through their C-terminal tails, but removing the
C-terminal tail of either protein has no effect on PC1 surface localization in human embryonic kidney 293 cells. Experiments
in polarized LLC-PK cells show that apical and ciliary PC1 localization requires PC2 and that this delivery is sensitive to PC2
truncation. In sum, our work shows that PC2 expression is required for the movement of PC1 to the plasma and ciliary
membranes. In ﬁbroblast cells this localization effect is independent of PC2’s channel activity or PC1 binding ability but
involves a stimulation of PC1’s GPS cleavage before the PC1 protein’s surface delivery.
INTRODUCTION
Most membrane proteins must be targeted to speciﬁc and
restricted subcellular locations to function optimally. Con-
sequently, cells have developed intricate signaling pathways
and trafﬁcking machinery to guarantee the proper establish-
ment and maintenance of these localizations. Mislocalization
of functionally important proteins can be detrimental at the
cellular and organismal levels, and some genetic diseases
are attributable to pathogenic mutations that alter a partic-
ular protein’s distribution (Seabra et al., 2002; Muth and
Caplan, 2003). This correlation between abnormal pathology
and protein localization is certainly true in the case of an
interesting subset of mutant alleles of the genes PKD1 and
PKD2, which encode the membrane proteins polycystin
(PC)1 and PC2, respectively. Mutations in PKD1 or PKD2
cause autosomal dominant polycystic kidney disease (ADPKD), a
common genetic disease affecting approximately one in a
thousand individuals. The disease causes progressive cyst
formation in the adult kidney, resulting in end-stage renal
failure in approximately half of all ADPKD patients by their
sixth decade of life (Gabow, 1993). Many pathogenic muta-
tions in the gene encoding PC1 result in the production of
little or no full length PC1 protein. Other disease-causing
mutations of PC1, however, lead to the generation of PC1
protein that does not accumulate in at least one of its sites of
functional residence (Roitbak et al., 2004; Russo et al., 2005).
Furthermore, mutations in the tuberous sclerosis 2 protein,
which may play a role in ensuring the proper trafﬁcking of
PC1, also is associated with a polycystic kidney phenotype
(Kleymenova et al., 2001). The connection between mislocal-
ization of PC1 and severe kidney pathology reveals the
critical importance of the cellular mechanisms that ensure
the proper subcellular trafﬁcking and retention of the PC1
protein.
There is robust expression of PC1 and PC2 in the epithelial
cells of the developing and mature renal tubules, as well in
the cells of a variety of other somatic tissues, including the
heart, liver, bone, and endocrine glands (Ward et al., 1996;
Markowitz et al., 1999; Peters et al., 1999). Within the cell,
polycystin-1 and -2 colocalize to the primary cilia where
they play roles in calcium signaling, mechano- and chemo-
sensation, and the modiﬁcation of signaling cascades such as
the Janus tyrosine kinase (JAK)/signal transducer and acti-
vator of transcription (STAT), activator protein (AP)-1, and
the Wnt pathways (reviewed in Veland et al., 2009. Polycys-
tin-2 is a transient receptor potential channel family member
that acts as a calcium-activated calcium release channel and
is most abundantly localized to the endoplasmic reticulum
(Cai et al., 1999; Koulen et al., 2002). PC2 and PC1 are thought
to interact primarily through their C-terminal cytoplasmic
tails (Qian et al., 1997; Tsiokas et al., 1997; Casuscelli et al.,
2009). Several investigations have suggested that PC1 and
PC2 may reciprocally affect each other’s surface membrane
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4338or ciliary localizations, although the precise nature of this
interdependence has varied somewhat among experimental
systems (Hanaoka et al., 2000; Grimm et al., 2003; Babich et
al., 2004). An interaction between these two proteins also has
been suggested to be important in creating a functional
ion channel, whether through activation of the PC2 pro-
tein’s intrinsic channel properties or through emergent
channel properties attributable to formation of the com-
plex (Hanaoka et al., 2000; Delmas et al., 2004).
PC1 is a very large protein that undergoes several cleav-
ages during its processing and movement through the se-
cretory pathway. One of these cleavages occurs at a G pro-
tein-coupled receptor proteolytic site (GPS), which is located
at a position in the PC1 protein’s extracellular N-terminal
domain just before the beginning of the ﬁrst transmembrane
domain (Qian et al., 2002). Cleavage at this site involves a
cis-autoproteolytic event that occurs early in the secretory
pathway (Wei et al., 2007). Missense mutations in PC1 resi-
dues that are required for the autocatalytic GPS cleavage
severely impair the normal functions of the PC1 protein, as
evidenced by the capacity of these mutations to cause
ADPKD (Qian et al., 2002). In addition, the ability of the PC1
protein to undergo successful GPS cleavage seems to be a
prerequisite for proper kidney development, because evi-
denced by the cystic phenotype observed in mice that are
homozygous for the expression of noncleaving PC1 alleles
(Yu et al., 2007). Two other cleavages take place at the
cytoplasmic C-terminal tail of PC1, releasing fragments that
translocate to the nucleus and modify the AP-1 and JAK/
STAT signaling pathways (Chauvet et al., 2004; Low et al.,
2006). The extent of C-terminal cleavage is modulated by
changes in ﬂuid ﬂow, consistent with the hypothesis that
production of soluble cytoplasmic fragments contributes to
the PC1 protein’s postulated role as a participant in mech-
anosensory functions (Chauvet et al., 2004).
Naturally occurring mutations in PC2 suggest important
information about the protein’s possible functions. One vari-
ant identiﬁed in ADPKD families substitutes the aspartic
acid residue at position 511 in the protein’s third predicted
transmembrane domain with a valine residue (D511V)
(Reynolds et al., 1999). The aspartic acid residue at position
511 is thought to constitute part of the PC2 channel’s con-
ducting pore, and the PC2-D511V protein has no channel
activity and exerts dominant-negative effect on the activity
of endoplasmic reticulum (ER) calcium release channels
when it is expressed by transfection in cultured cells (Koulen
et al., 2002; Ma et al., 2005). The localization of the D511V
protein, however, is indistinguishable from that of wild-type
PC2 (Koulen et al., 2002). Many investigators also have stud-
ied the properties of a PC2 protein in which a stop codon has
been inserted immediately after the leucine at residue num-
ber 703 (L703X). This truncation eliminates most of the PC2
protein’s cytoplasmic C terminus. The L703X truncated PC2
protein is structurally similar to the PC2 proteins produced
by several naturally occurring disease-causing truncating
mutations found in ADPKD patients (Koulen et al., 2002).
The L703X truncating mutation eliminates a domain of the
PC2 that interacts with PC1 (Qian et al., 1997), and the
protein lacks the calcium- or voltage-based regulation of
channel activity that is detected in the wild-type protein
(Koulen et al., 2002). The extent to which PC1 undergoes at
least one of its C-terminal cleavages seems to be affected
by the expression of wild-type and mutated forms of PC2
(Bertuccio et al., 2009).
Clearly, the PC1 and PC2 proteins exhibit a complex and
delicate interdependence in the regulation of their localiza-
tions and functions, both with respect to their independent
activities and in their collaboration as members of the same
complex. Much remains to be learned about the molecular
and mechanistic details of this interdependence. Here, we
present evidence that the localization of PC1 to the plasma
membrane depends on the presence of PC2. More speciﬁ-
cally, PC1 surface localization correlates with a PC2-stimu-
lated increase in GPS cleavage. This cleavage and localiza-
tion effect in human embryonic kidney (HEK)293 cells is
independent of any stable interaction between the two pro-
teins. It is also independent of PC2’s channel function, but
the surface localization effect is disrupted by the PC2-D511V
mutation. This evidence links PC2’s regulation of PC1 cleav-
age to an effect on PC1 localization, and, by extension, to
PC1 function.
MATERIALS AND METHODS
Cell Culture and Transfection
HEK293 and LLC-PK cells were grown at 37°C in DMEM or -minimal
essential medium, respectively (Invitrogen, Carlsbad, CA) supplemented
with 10% fetal bovine serum, 1% penicillin/streptomycin, and 1% l-glu-
tamine. Transient transfections were performed using the Lipofectamine 2000
reagent (Invitrogen), and the quantities of each of the PC2 cDNA constructs
used for transfection were adjusted to yield similar levels of protein expres-
sion as assayed by Western blot. Cells were assayed 24 h after transfection.
Stable expression of PC1 was established in HEK293 and LLC-PK cells by
using selection with G418 (Invitrogen). Stable PC2 expression was generated
using Zeocin (Invitrogen). Ionomycin and A23187 (Sigma-Aldrich, St. Louis,
MO) were added at the indicated concentrations for 30 min before processing
the cells for immunoﬂuorescence. To visualize cilia, LLC-PK cells were grown
on 0.4-m polycarbonate ﬁlters (Costar, a division of Corning Life Sciences,
Lowell, MA) for 5 d after reaching conﬂuence before being processed for
immunoﬂuorescence.
We used a full-length cDNA encoding the mouse Pkd1 that had been
modiﬁed to contain both an N-terminal FLAG and a C-terminal triple-hem-
agglutinin (HA) tags (Grimm et al., 2003). Construction of cDNA plasmids
expressing PC2, PC2-D511V, and PC2-L703X, all with c-Myc tags, have been
described previously (Cai et al., 1999). To generate cell lines stably expressing
these constructs, the coding sequence of tagged PC2 was moved to a vector
that carries Zeocin resistance (pcDNA3.1; Invitrogen). PC2-T712A, which
lacks a c-Myc tag, also has been characterized previously (Cai et al., 2004).
Antibodies
PC1 was detected using a polyclonal anti-FLAG antibody (Sigma-Aldrich)
against the N-terminal epitope tag, or monoclonal anti-HA antibody (Co-
vance Research Products, Princeton, NJ) against the C-terminal epitope tags.
Monoclonal anti-HA antibodies conjugated to agarose beads were used for
immunoprecipitation (Sigma-Aldrich). Polycystin-2 was detected using anti-
c-Myc antibody (polyclonal from Sigma-Aldrich; monoclonal from Santa
Cruz Biotechnology, Santa Cruz, CA), or a polyclonal antibody against the
native PC2 protein’s N terminus (antibody B9, a gift from Dr. Stefan Somlo,
Yale University, New Haven, CT). Cilia were marked using a monoclonal
anti-acetylated tubulin antibody (clone 6-11B-1; Sigma-Aldrich). Goat anti-
mouse and anti-rabbit immunoglobulin G secondary antibodies were conju-
gated to Alexa Flour 594 and 488 dyes, respectively (Invitrogen). All dilutions
were 1:200 for immunoﬂuorescence and 1:2000 for Western blotting. For
Western blots, we used horseradish peroxidase-conjugated secondary anti-
bodies; anti-mouse was diluted 1:10,000 and ant-rabbit was diluted 1:5000
(Jackson ImmuoResearch Laboratories, West Grove, PA).
Surface Immunoﬂuorescence
HEK293 cells were grown on glass coverslips coated with poly-l-lysine,
whereas LLC-PK cells were grown on polycarbonate ﬁlters. To stain surface
protein the cells were incubated for1hi nahumidiﬁed chamber at 4°C with
polyclonal anti-FLAG antibody diluted in a blocking buffer of 0.1% bovine
serum albumin (BSA) in phosphate-buffered saline (PBS) with 100 nM CaCl2
and 1 mM MgCl2 (PBS). Cells were then washed with PBS, ﬁxed for 20
min in 4% paraformaldehyde, permeabilized in PBS with 0.3% TritonX-100
and 0.1% BSA, and blocked for 30 min in goat serum dilution buffer (GSDB;
16% goat serum, 120 mM sodium phosphate, 0.3% Triton X-100, and 450 mM
NaCl). They were then incubated for1hi nahumidiﬁed chamber with the
monoclonal anti-HA primary antibody diluted in GSDB, washed, and incu-
bated for 1 h with the Alexa Fluor-conjugated secondary antibodies diluted in
GSDB. For a more detailed description, see Chapin et al. (2009). The protocol
for immunoﬂuorescence without surface labeling takes cells straight to para-
formaldehyde ﬁx after washing with PBS and then continues as described
above.
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Images used for illustration were taken with Zeiss LSM510 Meta confocal
microscope. A single 0.5-m scan slice is shown, except in those images where
it is noted that a vertical z-stack of images was compressed to provide a single
view of the entire cell surface. For quantiﬁcation, 10 representative images of
each experimental condition were taken using an Axiophot microscope with
AxioVision software (Carl Zeiss, Thornwood, NY) by using identical expo-
sure conditions. In one experiment, the calculations were based on com-
pressed vertical z-stacks of confocal images, as noted. The images were then
analyzed with ImageJ (National Institutes of Health, Bethesda, MD) to calcu-
late the sum of the pixel intensities above a cut-off threshold determined to
eliminate background noise. This threshold was chosen based on analysis of
the ﬂuorescence intensity histograms associated with images of ﬁelds of
coverslips lacking cells. This pixel intensity total was then divided by the
number of cells that were positive for surface PC1 staining above the given
threshold, yielding a calculation of average pixel intensity per cell. To quan-
tify conditions with no PC1 surface expression, cells were counted using the
internal anti-HA antibody immunoﬂuorescence. A two-tailed t test was used
to compare conditions.
Immunoprecipitation, Biotinylation, Western Blots, and
Quantiﬁcation
Biotinylation was performed by incubating the cells with sulfo-NHS-SS-biotin
(Pierce Chemical from Thermo Fisher Scientiﬁc, Rockford, IL) in buffer (10
mM triethanolamine, 2 mM CaCl2, and 125 mM NaCl at pH 8.9) at 4°C for a
total of 40 min, followed by quenching with 100 mM glycine for a further 20
min. Lysis proceeded as described below, and labeled protein was precipi-
tated using streptavidin-coated agarose beads by rotating overnight at 4°C
(Gottardi et al., 1995). Washes and elution were performed as described for the
immunoprecipitation protocol.
Cell lysis was accomplished by sonication with three 5-s pulses at 40%
intensity in lysis buffer (100 mM NaCl, 1 mM EDTA, 50 mM Tris, pH 7.5, 1%
Triton X-100, and protease inhibitors [Complete Protease Inhibitor Tablet,
Roche Diagnostics, Basel, Switzerland]), and the lysates were cleared by
centrifugation at 18,000  g for 15 min at 4°C. Lysates were then mixed with
SDS-containing sample buffer and heated to 55°C for 10 min. For immuno-
precipitation from cleared lysates from a 12-well cell culture plate, monoclo-
nal anti-HA was added, either preconjugated to agarose beads (15 l, total
volume) or simultaneously with the addition of protein G beads (30 lo f
beads with 1 l of anti-HA antibody). After rotating overnight at 4°C the
samples were washed four times with lysis buffer, once with PBS, and eluted
off the beads with sample buffer at 55°C.
Prepared samples were run in an SDS buffer in a polyacrylamide gel
electrophoresis gel and elecrophoretically transferred to a nitrocellulose mem-
brane (Bio-Rad Laboratories, Hercules, CA). After blocking for one hour in
150 mM NaCl, 20 mM Tris, 5% (wt/vol) powdered milk and 0.1% Tween, the
blots were incubated with the speciﬁed primary antibody followed by the
species-appropriate horseradish peroxidase-conjugated secondary antibody.
Signal was visualized using chemiluminescence (GE Healthcare, Piscataway, NJ).
ImageJ software (National Institutes of Health) was used for densitometry.
RESULTS
Surface Localization of PC1
To visualize the pool of PC1 at the surface of cells, we used
a live-cell labeling protocol in which cells were incubated at
4°C with an antibody against the N-terminal FLAG epitope
of PC1, thereby labeling proteins that had reached the mem-
brane and were exposed to the extracellular space. The total
pool of protein was visualized using the immunoﬂuores-
cence signal produced by an antibody directed against the
C-terminal HA tag on the PC1 construct, applied to cells
after ﬁxation and permeabilization. This immunoﬂuores-
cence protocol revealed that HEK293 cells transfected with
full-length PC1 alone showed a primarily intracellular local-
ization of the protein. When PC2 was transiently expressed
with PC1, there was a sevenfold increase in the size of the
Figure 1. Coexpression of channel-active PC2 constructs increases
the amount of PC1 at the surface of cultured cells. Unﬁxed, unper-
meabilized cells transiently transfected with PC1 were labeled using
an antibody directed against the extracellular FLAG epitope tag
appended to the N terminus of PC1 (A, a–d). The composites
presented here are compressed stacks of 15 confocal images. Inter-
nal PC1 was detected after ﬁxation and permeabilization using an
antibody directed against the C-terminal HA epitope on PC1 and
the images were merged to show colocalization at the plasma mem-
brane (i–l). There was minimal expression of PC1 on the surface
when it was expressed alone (a). These cells, however, expressed
PC1 internally, as seen with the antibody directed against the C-
terminal HA epitope tag (e). Coexpression of PC2 was associated
with the appearance of PC1 protein at the surface (b). PC2-D511V
had a substantially smaller effect on PC1 surface localization (c),
whereas PC2-L703X caused a distribution of PC1 similar to that seen
with PC2 (d). Quantiﬁcation of ﬁve representative compressed
stacks showed the extents of the increases in surface PC1 that
occurred in the presence of each of the PC2 constructs; asterisk
indicates p  0.05 compared with PC1 alone (B). To address the
issue of variable PC1 expression individual cells were imaged and
analyzed to determine the immunoﬂuorescence intensity of surface,
anti-FLAG antibody (C, top) and internal, anti-HA antibody (C,
bottom). For analysis, images were grouped so that images exhib-
iting similar levels of total PC1 expression could be compared across
conditions. Representative images from one such grouping are shown,
with the total above-background pixel intensity given in the lower
left corner of each image and the ratio of surface to internal immu-
noﬂuorescence given below the pictures. (C). Averaging the ratios
of six such groupings revealed that cells cotransfected with PC2 had
a 3.95  0.4-fold increase in surface PC1 compared with those
cotransfected with PC2-D511V.
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per-cell pixel intensity (Figure 1). When PC1 was coex-
pressed with PC2-L703X there was an increase in plasma
membrane localization similar to that seen with wild-type
PC2, but coexpression with PC2-D511V resulted in the ap-
pearance of substantially less PC1 at the surface (Figure 1, A
and B). PC1 reached the plasma membrane only in cells that
coexpressed PC2 (Supplemental Figure 1).
It was clear that the coexpression of PC2 caused an in-
crease in the total amount of PC1 protein in the cells, as seen
by anti-HA antibody immunoﬂuorescence. To ensure that
the difference between PC1 localization associated with
wild-type PC2 and PC2-D511V coexpression was not due to
this difference in the size of the cellular PC1 protein pool, we
performed a titration analysis in which varying quantities of
PC1 cDNA were cotransfected with the various PC2 con-
structs. Confocal images of individual cells were obtained
and the surface staining detected in these cells was then
compared among cells that exhibited similar anti-HA anti-
body immunoﬂuorescence pixel intensities (Figure 1C). This
more reﬁned comparison conﬁrmed that the surface local-
ization of PC1 in the presence of PC2 was fourfold higher
than the surface localization in the presence of PC2-D511V.
PC1 Surface Localization Correlates with GPS Cleavage
Cleavage of PC1 at its GPS site produces two main frag-
ments: an N-terminal piece comprised of the protein’s
3000 amino acid extracellular N terminus and a 145-kDa
piece corresponding to the PC1 protein’s 11 transmembrane
domains and its cytoplasmic C-terminal tail, termed the
C-terminal fragment (CTF; Qian et al., 2002). The CTF band
was clearly visible on a Western blot of lysates prepared
from transfected HEK293 cells probed with an antibody
directed against the HA epitope tag that is appended to the
C terminus of our PC1 construct (arrowhead in Figure 2A).
Coexpressing PC2 with PC1 resulted in a twofold increase in
the relative amount of PC1 CTF present in the cells, as
quantiﬁed by densitometry and normalized to the total ex-
pression of PC1. Coexpressing PC2-L703X caused a similarly
signiﬁcant increase in PC1 cleavage, but PC2-D511V de-
creased the relative amount of the CTF fragment compared
with the total amount of PC1 (Figure 2, A and B). It is worth
noting that there was an overall increase of PC1 protein
levels in cells that coexpress PC2, as seen in the immunoﬂu-
orescence experiment depicted in Figure 1 and as documented
previously (Tsiokas et al., 1997). The fact that PC2-L703X
changes the ratio of GPS cleavage without dramatically in-
creasing PC1 protein levels, however, suggests that these
two effects of PC2 expression are mechanistically distinct.
The pool of PC1 brought to the plasma membrane by each
of the PC2 constructs was predominantly GPS-cleaved, as
detected by cell surface biotinylation. Essentially all of the
PC1 protein that could be labeled by cell surface biotinyla-
tion had undergone GPS cleavage; whereas both the full-
length and CTF forms of PC1 were readily detected on
Western blots of the lysate from HEK293 cells expressing
PC1 and PC2, protein found in streptavidin pull-downs
prepared from surface biotinylation of these cells contained
CTF (Figure 2C). Consistent with the conclusion that un-
cleaved PC1 is largely absent from the cell surface, blotting
with the antibody directed against the N-terminal FLAG
epitope did not detect any full-length protein in the material
recovered through surface biotinylation. Perhaps surpris-
ingly, the cleaved N-terminal fragment was also not de-
tected among the biotinylated proteins. It is possible that the
structure of this domain of the PC1 protein precludes its
lysine residues from being readily accessible to the NHS-SS-
biotin reagent. Our preliminary observations, however, sug-
gest the interesting alternative possibility that the conditions
used in the biotinylation assay actually elute the N-terminal
fragment from its noncovalent attachment to the membrane-
associated PC1 C-terminal tail fragment (data not shown).
Were this the case, then the absence of the N-terminal frag-
ment from the pool of proteins collected after biotinylation
would be consistent with the possibility that the majority of
the surface population of PC1 has undergone GPS cleavage.
We conclude that the presence of PC2 enhances GPS cleav-
Figure 2. Cleavage of PC1 at the GPS is correlated with PC2-induced
surface localization. Lysates from cells expressing PC1 alone or co-
transfected with PC2, PC2-D511V, or PC2-L703X were immunoblotted
with an antibody directed against the C-terminal HA tag of PC1,
revealing the full-length PC1 band (arrow) and the large fragment
resulting from cleavage at the GPS site (arrowhead, A). Expression of
PC2 was veriﬁed using anti-PC2 antibody (A, bottom). The proportion
of GPS-cleaved PC1 was calculated as the intensity of the GPS-cleaved
protein band divided by the quantity of total PC1 protein expression,
which was itself determined by summing the densities of the three
major bands visible by Western blot: full-length, 150-kDa, and 70-kDa
bands (B). Western blotting revealed that the 70-kDa band is not
detected in untransfected cells (data not shown). Asterisk indicates
signiﬁcant increase or decrease in comparison to PC1 expressed alone
(p  0.05), and error bars indicate SE. Comparing the lysate and the
surface protein in HEK cells expressing PC1 and PC2, as detected using
surface biotinylation and streptavidin pull-down (lanes labeled Sur-
face), showed that most of the surface PC1 had been GPS-cleaved (C,
top). There was no full-length PC1 detected in the biotinylated fraction
(arrow, C). Blotting with an anti-FLAG antibody showed that FLAG-
positive full-length PC1 protein was not present in the pool of surface
PC1 (C, bottom).
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is strongly correlated with the surface delivery of PC1.
Given the correlation between GPS cleavage and in-
creased PC1 surface localization we tested whether GPS
cleavage was a prerequisite for or a consequence of surface
delivery. PC1-L3040H is a form of PC1 that cannot be
cleaved at the GPS site due to the mutation of the requisite
leucine residue at the cleavage site (Figure 3A) (Wei et al.,
2007). When expressed alone, PC1-L3040H exhibited an in-
tracellular localization similar to that of wild-type PC1, but
it failed to reach the plasma membrane when coexpressed
with PC2 or PC2-L703X (Figure 3B). This lack of surface
localization was not attributable to inefﬁcient or incomplete
cotransfection with PC2, because the cells expressed both
PC1-L3040H and PC2 (Figure 3C). To conﬁrm these ﬁndings,
we biotinylated cells cotransfected with PC2 and either PC1
or PC1-L3040H. Under conditions in which the wild-type
PC1 protein was readily detected among the recovered bio-
tinylated cell surface proteins, no PC1-L3040H was detected
in this material by using antibodies directed against either
the PC1 N- or C-terminal epitope tags (Figure 3D).
The L3040H mutation prevented the cleavage of PC1 at
the GPS site, thus producing a PC1 protein in which the
extracellular N-terminal domain was permanently afﬁxed to
the membrane spanning C-terminal portion of the protein.
Because this mutation abrogated surface delivery, we next
assessed the surface delivery of the converse mutation, a
PC1-N-terminal deletion (PC1-NTD) construct lacking the
majority of the extracellular N-terminal domain (Figure 4A).
The deletion removed the receptor for egg jelly domain,
which is necessary for optimal GPS cleavage (Qian et al.,
2002), resulting in a very low amount of GPS cleavage even
in the presence of PC2 (Figure 4B). Under conditions of
coexpression with PC2 that produced abundant PC1 surface
delivery (arrows in Figure 3C), there was little or no PC1-
NTD detectable at the plasma membrane (arrowheads in
Figure 3C). It is possible that the L3040H and NTD muta-
tions cause misfolding of the PC1 protein or otherwise im-
pair its trafﬁcking through mechanisms independent of any
effect on GPS cleavage. It is safe to conclude, however, that
the essential role of cleavage in PC1’s surface delivery is not
attributable solely to the physical dissociation of some pu-
tative transport-inhibiting component residing in the PC1 N
terminus from the C-terminal fragment, because the PC1
NTD lacks most of the N-terminal fragment but fails to reach
the plasma membrane when coexpressed with PC2.
PC1 and PC2 are predicted to interact through their C
termini (Qian et al., 1997; Tsiokas et al., 1997). To test whether
the different effects of the PC1 and PC2 mutations could be
attributed to their effects on the binding between PC1 and
PC2 we performed coimmunoprecipitations of the com-
Figure 3. Impairing GPS cleavage in PC1 prevents PC1 plasma
membrane localization. The GPS-mutated PC1-L3040H (A) was not
delivered to the plasma membrane in association with any PC2
construct (arrowheads in B). This lack of surface delivery occurred
despite robust internal expression of the PC1-L3040H protein, as
seen by immunoﬂuorescence with an internal anti-HA antibody (B,
bottom). In contrast, PC1 was readily detected at the surface when
it was coexpressed with PC2 and imaged under identical conditions
(arrows in B, far left). PC2 was coexpressed with PC1 constructs
under both cotransfection conditions (arrows, C), and any cells that
expressed only one construct were most likely to express PC2 alone
rather than PC1 alone (arrowheads, C). Surface biotinylation under
conditions of coexpression with PC2 that revealed plasma mem-
brane labeling of PC1 did not reveal L3040H at the surface, as
detected with either anti-HA antibody (D, top) or anti-FLAG anti-
body (D, bottom).
Figure 4. The presence of a cleavable N-terminal tail on PC1 is
necessary for plasma membrane localization. An N-terminal dele-
tion construct of PC1 (PC1-NTD) was prepared by deleting 2760
amino acids from the N terminus of PC1 (A). Expressing this con-
struct in HEK293 cells yielded a fragment of the expected size for
full-length PC1-NTD (arrow in B), with a very small amount of
GPS-cleaved product (B, arrowhead denotes C-terminal cleavage
fragment). PC1-NTD was not brought to the plasma membrane by
coexpression with PC2, as seen using transfection and exposure
conditions that are sufﬁcient to produce localization of wild-type
PC1 to the surface (C).
H. C. Chapin et al.
Molecular Biology of the Cell 4342plex that PC1 formed with each PC2 construct. Both PC1
and PC1-L3040H stably bound PC2 and PC2-D511V,
whereas neither stably interacted with PC2-L703X (Figure
5A). The observation that PC1 could not form a stable
complex with PC2-L703X demonstrated that the PC2 C-
terminal tail is an obligate participant in the PC1-PC2
interaction. These results were in accordance with previ-
ous work that found that the domain of PC2 that interacts
with PC1 resides at the protein’s the C terminus (Qian et
al., 1996). PC1-NTD formed a stable complex with PC2
(Figure 5B), despite its lack of plasma membrane localiza-
tion when coexpressed with PC2.
This behavior highlights the fact that the PC2-binding
ability of the various PC1 constructs did not parallel their
surface localization patterns, suggesting the very surprising
conclusion that a stable interaction with PC2 is not required
for PC2-enhanced PC1 surface localization. This is a rather
remarkable and unexpected ﬁnding because previous stud-
ies indicated that expressing C-terminal mutations of PC1
that prevent the interaction between PC1 and PC2 altered
PC1’s effect on signaling pathways (Bhunia et al., 2002; Delmas
et al., 2002) and also prevented emergent physical properties
of the PC1–PC2 complex, such as channel function (Hanaoka
et al., 2000). Our data suggest that an as yet-uncharacterized
interaction may mediate the cleavage and localization effects
of PC2 on PC1, indicating that the nature and effect of the
polycystin proteins’ functional interrelationships may be
more complex than previously appreciated.
PC2 enhances the C-terminal cleavage of PC1(Bertuccio et
al., 2009), so to test whether the presence of the C-terminal
tail affects the capacity for surface localization of PC1, we
created and expressed a C-terminal deletion construct (PC1-
CTD, Figure 6A). The PC1 protein harboring this deletion
was retained intracellularly when expressed alone (data not
shown) but was brought to the surface by coexpression with
PC2 (Figure 6B). PC1-CTD also was brought to the surface
by PC2-L703X but was intracellular in the presence of PC2-
D511V (Figure 6C). Similar to wild-type PC1, cotransfection
with PC2 increased the overall PC1-CTD protein expression,
as seen by Western blot (Figure 6D). There was not a marked
increase in the relative proportion of GPS-cleaved protein
with PC2 coexpression, in contrast to the effect on wild-type
PC1. Coimmunoprecipitation to test the stability of an inter-
action between the two proteins revealed that PC2 copre-
cipitated with PC1-CTD (Figure 6E). These results imply
that domains other than the C-terminal tail of PC1 may
contribute to the interaction between these two proteins, in
contrast to the obligate participation of the PC2 C-terminal
tail in the proteins’ interaction.
Ion Flux and PC1 Surface Localization
A notable characteristic of PC2-D511V is its inability to
function as a calcium ion channel, distinguishing it in this
regard from both PC2 and PC2-L703X. To test whether
exogenously inducing an inward calcium ﬂux would allow
PC2-D511V to promote PC1 surface localization, we applied
ionophores to cells expressing PC1 and PC2-D511V. Neither
ionomycin nor A23187 signiﬁcantly increased the amount of
PC1 at the plasma membrane of HEK293 cells in the pres-
ence of PC2-D511V (Figure 7A).
Because the application of ionophores did not rescue
the effect of PC2-D511V on PC1, we used another PC2
mutant to distinguish whether the inability of D511V to
support PC1 surface delivery was due to its lack of chan-
nel activity or to an unidentiﬁed characteristic conferred
by the point mutation itself. The PC2-T721A mutation
abolishes calcium channel activity but does so by mutat-
ing a residue in the C-terminal tail rather than in the ion
pore (Cai et al., 2004). Expressing PC2-T721A with PC1
brought PC1 to the plasma membrane (Figure 7B). Impor-
tantly, PC2-T721A expression also promoted PC1 GPS
Figure 5. Both PC1 and PC1-L3040H stably bind PC2 and PC2-
D511V, whereas PC2-L703X fails to coimmunoprecipitate with ei-
ther PC1 construct. Protein complexes containing PC1 or L3040H
were immunoprecipitated (IP’d) using an antibody against the C-
terminal HA tag on PC1 and then the immunoprecipitates were
Western blotted with polyclonal anti-c-Myc antibody to detect the
presence of the c-Myc epitope appended to PC2 (A, top). Control
conditions in which PC2 constructs were expressed in the absence of
PC1 revealed that there is no nonspeciﬁc signal from the anti-c-Myc
antibody (A, right-most lanes). PC2 and PC2-D511V stably inter-
acted with both PC1 constructs, whereas PC2-L703X failed to be
pulled down with PC1 or PC1-L3040H (A, top). This failure of
PC2-L703X to coIP was not due to a lack of PC1 construct pull-
down, as shown by blotting the IP with polyclonal anti-HA anti-
body (A). PC1-NTD also robustly bound to PC2, as seen by PC2’s
presence in the pull-down from an IP with the anti-HA antibody
against PC1-NTD (B, left). The success of the IP is revealed by
Western blotting with anti-HA antibody, which detects PC1-NTD in
both the lysate and IP material (B, right).
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quantiﬁed in D). Western blotting revealed that T721A is
expressed at readily detectable levels (data not shown).
The conclusion from this experiment is that PC2’s channel
function is not required to stimulate PC1’s GPS cleavage
or localization to the plasma membrane. This also sug-
gests that the PC2-D511V mutation has a negative effect
on the protein’s function that is not limited to impairing
its channel function.
Localization in Ciliated Cells
The nonpolarized HEK293 cells provide a convenient and
experimentally tractable system in which to observe the
surface localization of polycystin proteins, but they yield no
information about whether PC1 localizes to the cilia or to
other polarized membrane domains. To investigate PC1 lo-
calization in polarized, ciliated cells we stably expressed
PC1 alone or with PC2 constructs in LLC-PK cells. We grew
cells on ﬁlters to allow complete polarization and then per-
formed surface immunoﬂuorescence against the N-terminal
FLAG epitope to label PC1 at the plasma membrane. PC1
failed to substantially reach either the surface of the primary
cilium or the cellular apical membrane when expressed
alone (Figures 8, A and A). Coexpression of PC1 with PC2
caused robust PC1 localization to the primary cilium (Figure
8B) and the apical plasma membrane (Figure 8B). This
localization was revealed even more clearly in the cross-
sectional view showing surface PC1 in the apical and ciliary
plasma membranes (Figure 8D). Coexpressing PC1 with
PC2-D511V supported very weak ciliary accumulation of
PC1, and no delivery of the protein to the apical membrane
(Figure 8, C and 8C). PC2-L703X failed to support any
surface localization of PC1 (Figure 8, D and D). All cell lines
expressed comparable total amounts of PC1 protein (Figure
7, e–h). Variation in surface delivery was not due to PC2
expression, because cell lines transfected with PC2 had ro-
bust PC2 expression at the protein level (Figure 8E). Low
levels of the endogenous PC2 protein were detected using
the antibody against the N terminus (Figure 8E), suggesting
that the presence of endogenous protein might explain the
low level of ciliary PC1 observed in cell lines not stably
transfected with PC2 cDNA.
DISCUSSION
We have shown that PC2 increases the autocatalytic cleav-
age of PC1 at its GPS site and that this cleavage correlates
with movement of PC1 to the plasma membrane. Our results
suggest that the increase in GPS cleavage is a prerequisite for
surface delivery, rather than being a result of PC1 reaching
the plasma membrane. In nonpolarized cells coexpressing
any one of the four PC2 constructs tested, the amount of GPS
cleavage correlates closely with the corresponding measure-
ment of the intensity of the surface PC1 immunoﬂuores-
cence signal. Our results also suggest that the cleavage oc-
curs before PC1 arrives at the plasma membrane, because
the population of PC1 that is detected at the cell surface is
GPS cleaved. Furthermore, constructs in which this cleavage
is prevented, including the PC1-L3040H and PC1-NTD con-
structs, are retained in the endoplasmic reticulum and do
not reach the plasma membrane. These observations com-
plement and are entirely consistent with the evidence gath-
ered by Wei et al. (2007) showing that GPS cleavage takes
place early in the secretory pathway.
The use of a surface immunoﬂuorescence protocol allows
us to measure quantitatively the PC1 surface population and
to relate this localization to other aspects of the protein’s
processing. It has been clear from prior work that there is an
effect of PC2 on PC1’s localization, but the constructs and
imaging protocols used had an important inﬂuence on the
results obtained. In particular, in previous results from our
own laboratory, Grimm et al. (2003) found a lack of PC1 at
the plasma membrane in cells that coexpressed PC2 (2003).
The cDNA encoding PC1 that was used in these experiments
carried an inserted ClaI restriction site that was engineered
into the protein’s coding sequence to facilitate the construc-
Figure 6. Removing the cytoplasmic C-terminal tail of PC1 does
not inhibit either surface delivery or its interaction with PC2 con-
structs. A PC1 C-terminal deletion protein, PC1-CTD, was created
by deleting the 179 amino acids that immediately follow the ﬁnal
transmembrane domain (A). Surface immunoﬂuorescence with an-
ti-FLAG antibody revealed PC1-CTD at the plasma membrane
when it was cotransfected with PC2, similar to wild-type PC1 co-
transfected with PC2 (B, top). Cotransfecting PC2-D511V failed to
bring PC1-CTD to the surface (C, top left); instead, the protein was
only detected intracellularly (C, bottom left). PC1-L703X, however,
brought PC2-CTD to the plasma membrane (C, top right). A West-
ern blot by using the anti-HA antibody on lysates of HEK293 cells
transfected with the indicated plasmids showed that PC2 increased
the abundance of PC1-CTD but did not increase the relative amount
of GPS cleaved PC1-CTD protein, indicated with an arrowhead (D).
Immunoprecipitating with an anti-HA antibody directed against the
C-terminal tail of PC1-CTD and Western blotting with anti-c-Myc
antibody against the c-Myc-tagged PC2 showed that PC1-CTD
pulled down PC2 (E, top left). The coIP of PC2 with full-length PC1
is shown for control. PC2 protein was present in both lysates (E,
bottom left). The amount of PC1 protein pulled down in each IP is
shown by Western blotting with the polyclonal anti-HA antibody
(E, right). The arrowhead points to the C-terminal tail from PC1-
CTD protein, and asterisks indicate nonspeciﬁc bands produced by
the polyclonal antibody.
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ation that resulted from this insertion was located very close
to the subsequently discovered GPS cleavage site. We have
found that this alteration signiﬁcantly reduces the GPS
cleavage of the PC1 protein, which both explains the per-
plexing lack of PC1 surface localization observed in the
Grimm et al. (2003) study and further underscores the im-
portance of GPS cleavage for surface localization.
Several other studies have examined the parameters that
govern the localization of both endogenous and transfected
PC1 expressed in cultured cells. Imaging PC1 in Madin-
Darby canine kidney (MDCK) cells has revealed PC1 at the
lateral plasma membrane, in some cases colocalizing with
E-cadherin (Peters et al., 1999; Boletta et al., 2001; Roitbak et
al., 2004). Biotinylation experiments on stably transfected
MDCK indicate the PC1 present at the lateral plasma mem-
brane is full-length and not GPS cleaved (Boletta et al., 2001).
Although Boletta et al. (2001)did not transfect PC2 with PC1,
other studies have found a signiﬁcant amount of endoge-
nous PC2 in MDCK cells, so the requirement for PC2 coex-
pression may still hold in these cells (Scheffers et al., 2000).
The presence of full-length protein at the lateral membranes
of polarized cells, in contrast to the GPS-cleaved form of PC1
that we detect at the plasma membranes of nonpolarized
cells, suggests that the different forms of PC1 may have
functionally distinct roles, and strengthens the argument
that regulating cleavage also may regulate localization.
In another study employing polarized cells, Roitbak et al.
(2004) found normal levels of PC1 expression but reduced
levels of PC1 at the plasma membrane in kidney cells cul-
tured from tissue excised from ADPKD patients. They at-
tributed this effect to excessive phosphorylation of the PC1
protein. This study did not determine the nature of disease-
causing mutations in the gene encoding the PC1 protein. It
would be interesting to determine whether these mutations
affected GPS cleavage without altering protein expression
levels.
In a study employing nonpolarized cells, Babich et al.
(2004) found that PC1 colocalized with the plasma mem-
brane marker CD4 when it was expressed in the presence of
PC2 in CHO cells, similar to our results with HEK cells. They
also concluded that expression of PC2-D511V was sufﬁcient
to induce accumulation of PC1 at the plasma membrane and
that a PC1 construct lacking a portion of its N-terminal
domain could reach the plasma membrane. It is important to
note that these effects were quantiﬁed by measuring channel
conductance induced by PC1 and PC2 expression and by
assessing these proteins’ presence at the cell surface by the
extent of their colocalization with a plasma membrane marker
(Babich et al., 2004). Their marker for PC1 at the surface
membrane was its colocalization with CD4, but we could not
detect any surface PC1 in CHO cells using our surface
immunoﬂuorescence protocol (data not shown). It is possi-
ble that the CHO cell line that they used may have expressed
relatively high levels of endogenous wild-type PC2 com-
pared with the cells used in our studies. It is also worth
noting that their electrophysiological assay is likely to be
able to detect very small surface populations of active PC1–
PC2 channel complexes, whereas their ﬂuorescence assay
may not be able to distinguish among bulk populations of
proteins associated with submembranous compartments lo-
cated close to the cell surface from the much smaller contin-
gents that have attained a bona ﬁde surface localization
(Babich et al., 2004).
We demonstrate that the effect of PC2 on PC1 localization
is independent of a stable interaction between the two pro-
teins. The PC2-D511V mutant stably binds PC1 but does not
increase the amount of PC1 at the plasma membrane,
whereas the truncated PC2-L703X cannot bind PC1 but still
promotes its surface delivery. This suggests that the release
Figure 7. The surface localization and cleavage effects
of PC2 coexpression on the PC1 protein are not mim-
icked by induced calcium ion ﬂux and are independent
of PC2’s channel activity. PC2-D511V was expressed
along with PC1, and cells were then treated with 1 M
of the ionophores A23187 or ionomycin. Exogenously
inducing an ion ﬂux with either drug failed to alter the
localization of PC1, as quantiﬁed from images of surface
localization (A). The channel-defective mutant PC2-
T721A brought PC1 to the surface, as seen in a super-
position of a stack of confocal images (B). Cells in both
conditions exhibited PC1 at the plasma membrane as
seen with the immunoﬂuorescence signal from surface
anti-FLAG antibody directed against PC1 (B, top). There
was no statistical difference between the per-cell pixel
intensity of surface immunoﬂuorescence associated
with cells expressing PC1 and either PC2 or PC2-T721A,
with p  0.9. Coexpression with either PC2-T721A or
wild-type PC2 increased PC1 GPS cleavage to similar
extents, as seen both on Western blot (C) and in quan-
tiﬁcations of replicates of these experiments (D). Aster-
isk indicates p  0.05 compared with PC1 alone.
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release of PC1 from associations with chaperone proteins
upon PC2 binding to form a heterodimeric complex with
PC1, a mechanism that regulates the surface delivery of a
other multimeric membrane protein complexes (Zerangue et
al., 1999). The dramatically different degrees of enhancement
of PC1 GPS cleavage produced by PC2-L703X and PC2-
D511V also shows that stimulating GPS cleavage neither
requires nor is guaranteed by a stable interaction with PC1.
The results obtained with the PC1-CTD construct reveal
several signiﬁcant details of PC2’s effect on PC1 expression
and cleavage. The most apparent is that, though the coiled-
coil region of PC1 has been shown to bind PC2 in isolation
from the rest of the PC1 protein (Qian et al., 1997), the fact
that our PC1-CTD construct lacks the coiled-coil domain but
still binds PC2 suggests that there are likely to be additional
domains of in PC1 that are involved in the PC2 interaction.
In regard to the effect of PC2 on PC1 stabilization and
cleavage, coexpressing PC2 elevates PC1-CTD protein ex-
pression but does not increase the proportion of GPS-
cleaved protein, suggesting that the stabilization and cleav-
age effects of PC2 on PC1 are mechanistically distinct.
Figure 8. Coexpression with PC2 promotes PC1 localization to the apical and ciliary plasma membranes in polarized cells. LLC-PK cells
stably expressing PC1 alone or together with PC2, PC2-D511V or PC2-L703X were grown to conﬂuence and surface labeled with antibody
directed against the N-terminal FLAG epitope (A, a–d and B, a–d). They were then permeabilized and labeled with an antibody directed
against ciliary acetylated tubulin (A e-h), or the C-terminal HA epitope on PC1 (B, e–h). A small amount of PC1 was detectable on the
primary cilium when PC1 was expressed alone (Aa). Expressing PC2 with PC1 dramatically increased the amount of PC1 at the ciliary
membrane (Ab). Both PC2-D511V and PC2-L703X failed to stimulate PC1 delivery to the ciliary membrane (A, c and d). The anti-FLAG
antibody gives no detectable ciliary background signal in untransfected cells (C). Images created by merging stacks of 20 successive Z plane
confocal images reveal the extent to which PC1 is present at the apical and ciliary membranes (B, a–d) as well as the total amount of PC1
in the cells (B, e–h). Although all cell lines possess comparable amounts of total PC1 (B, e–h), PC1 is present at both the apical and ciliary
membranes only when PC1 is expressed with PC2 (Bb). A cross-section of the cells along the X-Z planes shows the presence of surface PC1
both at the apical membranes and in a pattern that colocalizes with that of the ciliary marker, an antibody directed against acetylated tubulin
(E). A Western blot using an antibody directed against an N-terminal region of PC2 shows robust PC2 expression in the stable cell lines (E,
top). A darker exposure shows low levels of endogenous PC2 in untransfected (WT) LLC-PK cells, and cells only transfected with PC1 (E,
bottom).
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intact PC1 C-terminal tail is necessary for the enhancement
of GPS cleavage. Our results suggest that the majority of the
PC1 proteins that are present at the surface have intact C
termini, because immunoﬂuorescence analysis of PC2 coex-
pressing cells reveals surface patterns for the PC1 protein
with both the anti-FLAG and anti-HA antibodies. Further-
more, biotinylated PC1 protein from the surface of cells
expressing PC1 and PC2 is detectable with the anti-HA
antibody on a Western blot. Together, these data suggest the
possibility that PC1 protein with an intact C-terminal tail is
the substrate for PC2-stimulated GPS cleavage, and this
protein subsequently moves to the surface. Given that the
C-terminal tail has multiple signaling roles once cleaved
(Chauvet et al., 2004; Low et al., 2006), the prevalence of PC1
with an intact C-terminal tail at the plasma membrane sug-
gests a spatial and possibly functional distinction between
forms of PC1 that differ with respect to the states of their C
termini.
The surprising incongruity in the effects of PC2-D511V
and PC2-T721A on PC1 surface localization in nonpolarized
cells underscores the signiﬁcance of GPS cleavage in the
promotion of trafﬁcking PC1 to the plasma membrane. Both
PC2-D511V and PC2-T721 are reported to manifest defective
channel activity. Whereas PC2-D511V does not support PC1
GPS cleavage or surface delivery, both of these activities are
accomplished by PC2-T721A. This is strong evidence that
PC2’s channel function is not the principle characteristic
through which it mediates its effect on PC1 cleavage and
distribution. We believe that, with respect to its effects on
PC1 surface delivery, the signiﬁcant point of difference be-
tween PC2-D511V and wild-type PC2 resides in the inability
of the mutant PC2-D511V to promote GPS cleavage of PC1.
This cannot be explained by a difference in the subcellular
localizations of the wild type and D511V mutant PC2 pro-
teins or by their capacity to interact physically with PC1
(Reynolds et al., 1999; Ma et al., 2005). We conclude that the
regulation of GPS cleavage is dependent upon as yet unap-
preciated aspects of PC2 function and that further study will
be necessary to understand how the D511V point mutation
could cause such a dramatic shift in the functional link
between PC1 and PC2.
The results obtained with polarized epithelial cells expand
and provide important context for our understanding of
PC2-enhanced PC1 plasma membrane delivery. In the kid-
ney, the native polycystin proteins are expressed in the
polarized epithelial cells of the renal tubules. Unlike the
ﬁbroblastic HEK293 cells, these cells possess plasma mem-
branes divided into distinct apical and basolateral domains
and contain sensory primary cilia. Thus, the surfaces of these
cells provide a complex array of trafﬁcking options to the
machinery that controls the localization and physiological
effects of PC1 and PC2. Given this distinction between po-
larized and nonpolarized cells, we thought it both important
and potentially illuminating to expand ﬁndings from ﬁbro-
blast cells into polarized cells. Our stable LLC-PK cell lines
conﬁrmed that expression of PC2 stimulates and is required
for PC1 to achieve plasma membrane localization. This effect
could be developmentally signiﬁcant, given the nonsynchro-
nous changes in PC1 and PC2 expression in the developing
kidney: PC1 is most strongly expressed early in develop-
ment, whereas PC2 expression is higher in mature tubules
(Ward et al., 1996; Markowitz et al., 1999; Chauvet et al.,
2002). Our results suggest that PC2 coexpression both in-
creases PC1 protein levels and alters its localization. Hence,
alterations in PC2 expression may coordinately affect PC1
levels and localization. Further study is needed to test this
hypothesis in the developing tubule, as well as to determine
whether there are the functional differences between the
pools of PC1 molecules present at internal and plasma mem-
brane locations.
We were quite surprised to ﬁnd substantial differences in
the capacity of mutant forms of PC2 to support PC1 cell
surface delivery in polarized versus ﬁbroblastic cells. The
most notable of these differences was that PC2-L703X failed
to support PC1 localization to either the apical plasma mem-
brane or the primary cilium in LLC-PK cells, whereas PC2-
L703X coexpression was sufﬁcient to ensure robust PC1
surface expression in HEK293 cells. In addition, PC2-D511V
expression allowed a very low level of PC1 delivery to the
primary cilium in LLC-PK cells, whereas as no surface PC1
expression was detected in HEK293 cells in which PC1 was
coexpressed with the PC2-D511V construct. Some of this
surface PC1 localization may be explained by the presence of
endogenous PC2, as detected by Western blot (Figure 8E).
Endogenous PC2 also may explain the low level of ciliary
membrane PC1 seen in cells not transfected with PC2. In
sum, the incongruence between PC1 localization in polar-
ized and ﬁbroblastic cells suggests the unexpected possibil-
ity that the processes and requirements that govern the
trafﬁcking of PC1 in polarized, ciliated cells differ from those
that operate in nonpolarized cells. Further studies are re-
quired to determine whether the postsynthetic pathways
pursued by PC1 in polarized versus nonpolarized cells are
governed by distinct itineraries, interactions, or check
points. It will also be interesting to determine whether the
presence of a cilium alters generates signals that inﬂuence or
alter the trafﬁcking options available to PC1.
Based upon our evidence, PC2 coexpression leads to the
delivery of PC1 to the plasma membrane, and more specif-
ically to the apical and ciliary membranes of polarized cells.
PC2 acts on PC1 early in the secretory pathway to promote
cleavage of PC1 at the GPS site, leading to delivery of PC1 to
the plasma membrane, and this effect is independent of a
stable physical interaction between the two proteins. Cleav-
age at the GPS site separates the intracellular pool of PC1
into two functionally distinct groups, as noted previously
(Wei et al., 2007), and we ﬁnd that the GPS-cleaved pool of
PC1 is characterized at least in part by its ability to reach the
membrane. A regulatory effect of PC2 on PC1 cleavage has
already been shown for the cytoplasmic PC1 cleavage
(Chauvet et al., 2004; Bertuccio et al., 2009), and results
shown here suggest that PC2 enhances the GPS cleavage as
well. Given that the majority of the surface population of
PC1 retains its cytoplasmic HA tag, PC2’s effects on C- and
N-terminal PC1 cleavages may be exercised on distinct pools
of PC1 protein that ultimately reside in different subcellular
compartments and that serve functionally distinct roles. It
remains to be determined whether there is any functional
relationship between the GPS cleavage and the C-terminal
tail cleavage, and whether it is the surface or ER pools of
PC1 that are preferentially susceptible to C-terminal tail
cleavage. Future studies will examine this relationship,
and explore the molecular processes through which PC2
expression inﬂuences the GPS cleavage and cell surface
delivery of PC1.
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